Annual CFF
$1.09 M
-$5.69 M-83.97%
31 December 2023
Summary:
Scinai Immunotherapeutics annual cash flow from financing activities is currently $1.09 million, with the most recent change of -$5.69 million (-83.97%) on 31 December 2023. During the last 3 years, it has fallen by -$3.18 million (-74.54%). SCNI annual CFF is now -95.59% below its all-time high of $24.61 million, reached on 01 December 2019.SCNI Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$12.00 K
-$1.41 M-99.16%
30 June 2024
Summary:
Scinai Immunotherapeutics quarterly cash flow from financing activities is currently $12.00 thousand, with the most recent change of -$1.41 million (-99.16%) on 30 June 2024. Over the past year, it has dropped by -$1.07 million (-98.90%). SCNI quarterly CFF is now -99.91% below its all-time high of $12.78 million, reached on 01 September 2017.SCNI Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$2.52 M
+$12.00 K+0.48%
30 June 2024
Summary:
Scinai Immunotherapeutics TTM cash flow from financing activities is currently $2.52 million, with the most recent change of +$12.00 thousand (+0.48%) on 30 June 2024. Over the past year, it has dropped by -$5.34 million (-67.96%). SCNI TTM CFF is now -88.75% below its all-time high of $22.39 million, reached on 01 December 2018.SCNI TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCNI Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.0% | -98.9% | -68.0% |
| 3 y3 years | -74.5% | - | - |
| 5 y5 years | -95.2% | - | - |
SCNI Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -94.9% | at low | -99.8% | -68.0% | ||
| 5 y | 5 years | -95.6% | at low | -99.8% | -68.0% | ||
| alltime | all time | -95.6% | +640.8% | -99.9% | +103.5% | -88.8% | +988.2% |
Scinai Immunotherapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | - | $12.00 K(-99.2%) | $2.52 M(+0.5%) |
| Mar 2024 | - | $1.42 M(>+9900.0%) | $2.51 M(+130.8%) |
| Dec 2023 | $1.09 M(-84.0%) | $0.00(-100.0%) | $1.09 M(-86.2%) |
| Sept 2023 | - | $1.09 M(>+9900.0%) | $7.86 M(+16.0%) |
| June 2023 | - | $0.00(0.0%) | $6.78 M(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $6.78 M(0.0%) |
| Dec 2022 | $6.78 M(-68.4%) | $6.78 M(>+9900.0%) | $6.78 M(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2022 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | $21.43 M(+402.4%) | - | - |
| Dec 2020 | $4.27 M(-82.7%) | - | - |
| Dec 2019 | $24.61 M(+9.9%) | - | - |
| June 2019 | - | -$36.80 K(-57.5%) | $15.36 M(-31.1%) |
| Mar 2019 | - | -$86.50 K(-101.0%) | $22.30 M(-0.4%) |
| Dec 2018 | $22.39 M(+25.8%) | $8.36 M(+17.3%) | $22.39 M(+57.1%) |
| Sept 2018 | - | $7.12 M(+3.1%) | $14.25 M(-28.4%) |
| June 2018 | - | $6.91 M(>+9900.0%) | $19.91 M(+34.7%) |
| Mar 2018 | - | $0.00(-100.0%) | $14.78 M(-16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | $17.79 M(>+9900.0%) | $220.00 K(-98.3%) | $17.79 M(+1.3%) |
| Sept 2017 | - | $12.78 M(+618.8%) | $17.57 M(+267.0%) |
| June 2017 | - | $1.78 M(-40.9%) | $4.79 M(+59.1%) |
| Mar 2017 | - | $3.01 M(>+9900.0%) | $3.01 M(>+9900.0%) |
| Dec 2016 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2016 | - | $0.00(0.0%) | $56.00 K(-119.7%) |
| June 2016 | - | $0.00(0.0%) | -$283.60 K(-103.3%) |
| Mar 2016 | - | $0.00(-100.0%) | $8.69 M(+0.5%) |
| Dec 2015 | $8.65 M(-4406.0%) | $56.00 K(-116.5%) | $8.65 M(+3.1%) |
| Sept 2015 | - | -$339.60 K(-103.8%) | $8.39 M(-3.9%) |
| June 2015 | - | $8.97 M(<-9900.0%) | $8.73 M(-3670.2%) |
| Mar 2015 | - | -$43.70 K(-78.2%) | -$244.50 K(+21.8%) |
| Dec 2014 | -$200.80 K(-107.6%) | -$200.80 K(<-9900.0%) | -$200.80 K(<-9900.0%) |
| Sept 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
| Dec 2013 | $2.66 M(+101.0%) | - | - |
| Dec 2012 | $1.32 M(+6.2%) | - | - |
| Dec 2011 | $1.24 M | - | - |
FAQ
- What is Scinai Immunotherapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics annual CFF year-on-year change?
- What is Scinai Immunotherapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics quarterly CFF year-on-year change?
- What is Scinai Immunotherapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Scinai Immunotherapeutics?
- What is Scinai Immunotherapeutics TTM CFF year-on-year change?
What is Scinai Immunotherapeutics annual cash flow from financing activities?
The current annual CFF of SCNI is $1.09 M
What is the all time high annual CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high annual cash flow from financing activities is $24.61 M
What is Scinai Immunotherapeutics annual CFF year-on-year change?
Over the past year, SCNI annual cash flow from financing activities has changed by -$5.69 M (-83.97%)
What is Scinai Immunotherapeutics quarterly cash flow from financing activities?
The current quarterly CFF of SCNI is $12.00 K
What is the all time high quarterly CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high quarterly cash flow from financing activities is $12.78 M
What is Scinai Immunotherapeutics quarterly CFF year-on-year change?
Over the past year, SCNI quarterly cash flow from financing activities has changed by -$1.07 M (-98.90%)
What is Scinai Immunotherapeutics TTM cash flow from financing activities?
The current TTM CFF of SCNI is $2.52 M
What is the all time high TTM CFF for Scinai Immunotherapeutics?
Scinai Immunotherapeutics all-time high TTM cash flow from financing activities is $22.39 M
What is Scinai Immunotherapeutics TTM CFF year-on-year change?
Over the past year, SCNI TTM cash flow from financing activities has changed by -$5.34 M (-67.96%)